Product Specifications

Key Features

• Rapid Dissolution: The ODT technology allows the tablet to melt on the tongue within seconds, facilitating easy administration without water.

• Patient Compliance: Ideal for pediatric, geriatric, or oncology patients who may suffer from “pill fatigue” or dysphagia (swallowing difficulties).

• Strawberry Flavored: Formulated with a pleasant strawberry taste to mask the bitter flavor of the active medication.

• Potent Relief: The 8 mg strength is the standard therapeutic dose for preventing moderate to highly emetogenic chemotherapy-induced nausea.

• Unit-of-Use Packaging: Provided in a 30-count bottle, suitable for a full course of post-operative or post-chemotherapy recovery.

Clinical Applications

• Chemotherapy-Induced Nausea (CINV): Prevention of nausea associated with moderately emetogenic cancer therapy.

• Radiation-Induced Nausea (RINV): Prevention of nausea in patients receiving total body irradiation or daily fractions to the abdomen.

• Postoperative Nausea (PONV): Prevention of nausea following surgical procedures.

• Acute Gastroenteritis: Off-label use in emergency settings to stop vomiting and prevent dehydration in adults and children.

⚠️ Usage Note: Do not push the tablet through the foil if in a blister (this SKU is a bottle). Ensure hands are dry before handling. Place the tablet on the tongue, allow it to dissolve, and swallow with saliva.

⚠️ Safety Alert: Contains Phenylalanine. Patients with Phenylketonuria (PKU) should be alerted as the ODT formulation often uses aspartame as a sweetener.

⚠️ Side Effects: Common side effects include headache, constipation, and fatigue. Serious risks include QT prolongation and Serotonin Syndrome when used with other serotonergic drugs.